Penkhae Limsila
Samut Prakan, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Pharmacogenomics Factors Influencing the Effect of Risperidone on Prolactin Levels in Thai Pediatric Patients With Autism Spectrum Disorder.
Journal: Frontiers in pharmacology
Published: July 18, 2021
Relationship between CYP2D6 genotype, activity score and phenotype in a pediatric Thai population treated with risperidone.
Journal: Scientific reports
Published: October 13, 2020
UGT1A1 polymorphisms associated with prolactin response in risperidone-treated children and adolescents with autism spectrum disorder.
Journal: The pharmacogenomics journal
Published: September 15, 2017
Pharmacogenetics of Risperidone-Induced Insulin Resistance in Children and Adolescents with Autism Spectrum Disorder.
Journal: Basic & clinical pharmacology & toxicology
Published: September 14, 2017
Pharmacogenomics and Efficacy of Risperidone Long-Term Treatment in Thai Autistic Children and Adolescents.
Journal: Basic & clinical pharmacology & toxicology
Published: February 17, 2017
Impact of risperidone on leptin and insulin in children and adolescents with autistic spectrum disorders.
Journal: Clinical biochemistry
Published: November 06, 2016
Pharmacogenomic Study Reveals New Variants of Drug Metabolizing Enzyme and Transporter Genes Associated with Steady-State Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone in Thai Autism Spectrum Disorder Patients.
Journal: Frontiers in pharmacology
Published: June 30, 2016
Hyperuricemia in Children and Adolescents with Autism Spectrum Disorder Treated with Risperidone: The Risk Factors for Metabolic Adverse Effects.
Journal: Frontiers in pharmacology
Published: June 15, 2016
Clinically relevant genetic variants of drug-metabolizing enzyme and transporter genes detected in Thai children and adolescents with autism spectrum disorder.
Journal: Neuropsychiatric disease and treatment
Published: April 26, 2016
Impact of Pharmacogenetic Markers of CYP2D6 and DRD2 on Prolactin Response in Risperidone-Treated Thai Children and Adolescents With Autism Spectrum Disorders.
Journal: Journal of clinical psychopharmacology
Published: February 13, 2016
Impact of CYP2D6 Polymorphism on Steady-State Plasma Levels of Risperidone and 9-Hydroxyrisperidone in Thai Children and Adolescents with Autism Spectrum Disorder.
Journal: Journal of child and adolescent psychopharmacology
Published: January 19, 2016
Last Updated: 09/26/2026